Clinical Trial Update: Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for tositumomab in combination with iodine-131 for treating chronic lymphocytic leukemia or small lymphocytic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Iodine-131 (Iodine-131)
• Tositumomab (tositumomab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Lymphoid Leukemia in Remission, Stage I Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-10-12